Cellular Health Screening Market Valued at US$ 2.6 Billion Set to Witness a High Growth rate of 9% in the next 5 years

Rising government initiatives towards preventive healthcare, rapid growth in geriatric population, increased funding & investments in R&D activities, growing adoption of direct-to-consumer approach, increasing applications of cellular health screening in personalized medicine, and huge burden of chronic diseases are some of the key factors driving the cellular health screening market.

(firmenpresse) - Cellular health screening or testing is one of the determinants of health based on certain factors such as lifestyle, environment, emotions and diet. It can be used to evaluate inflammatory diseases such allergies, asthma, arthritis, autoimmune diseases, or inflammatory gastrointestinal issues. This test also aids in monitoring a patient’s progress throughout the treatment and provide detailed reports to examine and assess improvements on a cellular level. Cellular health screening helps in determining cellular health & function, fat mass, intra & extracellular fluid levels, cellular toxicity, and muscle mass, among others.

Advancements in cellular health screening to fuel the demand in the Cellular Health Screening Market
The ongoing progress in screening tests for cellular health has facilitated the creation of user-friendly and effective tests that come with enhanced capabilities like automated identification of telomeres, rapid results, and heightened precision. Such advancements tend to provide competitive edge to manufacturers and therefore, major players are continuously focusing on new product development to strengthen their foothold in this high growth market.

Some of the technological advancements are listed below:
•In December 2022, Regenerus labs launched its TruAge Complete, an advanced epigenetic test that provide an accurate, comprehensive, and actionable analysis of a patient’s biological ageing and health insights
•In August 2022, Proteomics International Laboratories announced the spin-off of an independent business for the commercialization of its patented ‘2-tag’ technology developed together with The University of Western Australia
•In July 2022, Bloom Diagnostics, a Swiss med-tech company launched its Bloom Inflammation Test to test for the quantitative measurement and presence of C-Reactive Protein (CRP) using the Bloom system

Increasing research activities to drive innovation in cellular health screening market


Growth in the cellular health screening market is expected to be fueled by the Growing public awareness campaigns aimed at educating individuals about the symptoms of chronic diseases and how to prevent them in order minimise disease epidemics. Because of increased patient awareness and high demand, there is a substantial need for novel cellular health screening kits and services which has compelled researchers to focus on innovation and develop advanced diagnostic tests.
Some of these are listed below-
•In February 2023, Duke-NUS Medical School announced that Scientists at the Duke-NUS Medical School, National Heart Centre Singapore (NHCS) and colleagues in Singapore, China and the US have developed a test to quickly and precisely measure the length of a single telomere. The new approach is expected to be used as a predictive biomarker for human ageing and disease at the individual level
•In March 2021, Researchers at Queen Mary University of London and Cardiff University developed a rapid laboratory test for diagnosing patients exhibiting symptoms arising from telomeropathies. This high-throughput single telomere length analysis (HT-STELA) technique is a DNA-based blood test and can be applied to a broader range of samples including fresh or frozen blood samples

The cellular health screening market is a burgeoning industry that is poised to gather additional momentum in the near future. This can be attributed to the strong emphasis on innovation, greater acceptance and awareness of preventive healthcare, the rapid growth of the aging population, and increased efforts by market players to expand their geographic presence, among other factors. For instance, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time, the share of the population aged 60 years and over will expand from 1 billion in 2020 to 1.4 billion. Aging increases the risk of chronic diseases and infections which further demands preventive diagnostic tests, thereby driving the cellular health screening market growth.

Competitive landscape: Cellular Health Screening Market
The market is marked by the presence of key players such Quest Diagnostics (US); Telomere Diagnostics (US); SpectraCell Laboratories (US); Genova Diagnostics (US); LabCorp Holdings (US); Repeat Diagnostics, Inc. (Canada); Life Length (Spain); and others.Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Leseranfragen:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: Prathamesh
Datum: 14.07.2023 - 07:36 Uhr
Sprache: Deutsch
News-ID 2055087
Anzahl Zeichen: 4869

Kontakt-Informationen:
Ansprechpartner: Prathamesh Medi Tech
Stadt:

Brussels

Telefon: 0498868079

Kategorie:

Medizintechnik

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 14.07.2023

Diese Pressemitteilung wurde bisher 345 mal aufgerufen.

Growing Focus on Augmented Reality Spurs 13% CAGR in Global Bionic Contact Lense ...

Bionic contact lenses are an innovative blend of traditional contact lenses and advanced tech, promising to reshape vision correction and AR experiences by overlaying digital information in real time. They offer benefits such as addressing nearsighte ...

The Bioburden Testing Market Continues Upward Trend with a Projected 12-15% CAGR ...

Bioburden testing, an essential quality control process in pharmaceutical and medical device production, evaluates microbial contamination levels on products, raw materials, and manufacturing settings, including bacteria, fungi, yeasts, and molds. Th ...

The Cardiac Resuscitation Devices Market is Poised to achieve a CAGR of 6-7% by ...

Cardiopulmonary resuscitation (CPR), another name for cardiac resuscitation, is an emergency treatment given to people who are experiencing cardiac arrest—a condition in which the heart stops beating efficiently—in an emergency. In order to susta ...

Alle Meldungen von Medi-tech insights